Whole Blood Cells Loaded with Messenger RNA as an Anti‐Tumor Vaccine
- 16 December 2013
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 3 (6) , 837-842
Abstract
The use of a cell‐based vaccine composed of autologous whole blood cells loaded with mRNA is described. Mice immunized with whole blood cells loaded with mRNA encoding antigen develop anti‐tumor immunity comparable to DC‐RNA immunization. This approach offers a simple and affordable alternative to RNA‐based cellular therapy by circumventing complex, laborious and expensive ex vivo manipulations required for DC‐based immunizations.Keywords
This publication has 30 references indexed in Scilit:
- Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancerCancer Immunology, Immunotherapy, 2012
- Increased Erythropoiesis in Mice Injected With Submicrogram Quantities of Pseudouridine-containing mRNA Encoding ErythropoietinMolecular Therapy, 2012
- Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor TherapyCancer Research, 2012
- Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated PatientsMolecular Therapy, 2011
- Nitric oxide and redox mechanisms in the immune responseJournal of Leukocyte Biology, 2011
- CD8+ T Cell Priming by Dendritic Cell Vaccines Requires Antigen Transfer to Endogenous Antigen Presenting CellsPLOS ONE, 2010
- Opsonized erythrocyte ghosts for liver-targeted delivery of antisense oligodeoxynucleotidesBiomaterials, 2009
- Activated B cells modified by electroporation of multiple mRNAs encoding immune stimulatory molecules are comparable to mature dendritic cells in inducing in vitro antigen‐specific T‐cell responsesImmunology, 2008
- Phagocytic clearance of electric field induced ‘apoptosis-mimetic’ cellsBiochemical and Biophysical Research Communications, 2008
- Lymphocytes genetically modified to express tumor antigens target DCs in vivo and induce antitumor immunityJournal of Clinical Investigation, 2007